anmelden
SLI
2.208,68
PKT
+11,41
PKT
+0,52
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu SLI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 15.07.15 | Holcim overweight | JP Morgan Chase & Co. | |
| 15.07.15 | UBS Neutral | UBS AG | |
| 15.07.15 | UBS Outperform | RBC Capital Markets | |
| 14.07.15 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 14.07.15 | UBS overweight | JP Morgan Chase & Co. | |
| 14.07.15 | UBS overweight | JP Morgan Chase & Co. | |
| 14.07.15 | Swiss Re Underweight | JP Morgan Chase & Co. | |
| 14.07.15 | Nestlé overweight | JP Morgan Chase & Co. | |
| 14.07.15 | Swiss Re buy | Goldman Sachs Group Inc. | |
| 14.07.15 | Roche buy | UBS AG | |
| 13.07.15 | UBS overweight | Morgan Stanley | |
| 13.07.15 | UBS overweight | Morgan Stanley | |
| 13.07.15 | Novartis buy | Citigroup Corp. | |
| 13.07.15 | Novartis buy | Jefferies & Company Inc. | |
| 13.07.15 | Roche buy | Jefferies & Company Inc. | |
| 13.07.15 | Zurich Insurance Neutral | Citigroup Corp. | |
| 10.07.15 | Givaudan Hold | Société Générale Group S.A. (SG) | |
| 10.07.15 | Novartis buy | UBS AG | |
| 10.07.15 | Swiss Re Equal weight | Barclays Capital | |
| 10.07.15 | Zurich Insurance overweight | Barclays Capital | |
| 10.07.15 | Givaudan Neutral | BNP PARIBAS | |
| 09.07.15 | Novartis overweight | JP Morgan Chase & Co. | |
| 09.07.15 | Holcim buy | Deutsche Bank AG | |
| 09.07.15 | Nestlé Reduce | Nomura | |
| 09.07.15 | ABB (Asea Brown Boveri) Sell | Goldman Sachs Group Inc. | |
| 08.07.15 | Nestlé Hold | Deutsche Bank AG | |
| 08.07.15 | ABB (Asea Brown Boveri) Equal-Weight | Morgan Stanley | |
| 08.07.15 | Holcim overweight | JP Morgan Chase & Co. | |
| 08.07.15 | Roche overweight | JP Morgan Chase & Co. | |
| 07.07.15 | UBS overweight | JP Morgan Chase & Co. | |
| 07.07.15 | UBS overweight | JP Morgan Chase & Co. | |
| 07.07.15 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 07.07.15 | Novartis buy | UBS AG | |
| 06.07.15 | Givaudan buy | Deutsche Bank AG | |
| 06.07.15 | Novartis overweight | JP Morgan Chase & Co. | |
| 03.07.15 | Novartis buy | Citigroup Corp. | |
| 03.07.15 | Givaudan buy | Deutsche Bank AG | |
| 03.07.15 | Nestlé Hold | Société Générale Group S.A. (SG) | |
| 01.07.15 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 01.07.15 | UBS buy | Deutsche Bank AG |
